Navigation Links
AMBI Supports Skin of Color Society Research Award
Date:3/1/2013

MIAMI BEACH, Fla., March 1, 2013 /PRNewswire/ -- AMBI® Skincare is pleased to announce the annual AMBI Research Award with The Skin of Color Society, a grant of $15,000 to promote dermatology research within the field of skin of color. By providing essential funding to this program, AMBI and the Skin of Color Society are helping to shape the future of tomorrow's clinical leaders in dermatology, expressly in this specialized field.  

The grant addresses the issues specific to skin of color where further clinical and basic research is needed. The grant will assist a young dermatologist, a resident or within five years of graduation, in furthering his or her academic career. Requirements include a strong commitment to research with a focus that can include hyperpigmentation, anti-aging, scarring/stretch-marks, photo-protection, skin dryness or acne. Financial need will be taken into consideration as well.

This annual award is made possible by a generous grant from Valeant Pharmaceuticals, makers of AMBI Skincare Products, in the amount of $15,000.  "AMBI is dedicated to delivering scientifically proven solutions that address unique skincare needs, recognizing and celebrating the strength and beauty of women of color," said Alissa Hsu Lynch of Valeant Pharmaceuticals. "This grant takes our mission a step further and supports the dermatologists in this field of inquiry."

Dr. Valerie Callender , President of the Skin of Color Society and Board Certified Dermatologist, is known for her expertise in hyperpigmentation. "AMBI's longstanding commitment to the organization and to dermatological issues primarily affecting skin of color is reflected in this generous donation," said Dr. Callender. "The program fills a void in the industry where further study in these specialized topics is crucial. We are proud to partner with a brand that is devoted to these issues and appreciate the support they've pledged."

On February 28th, the grant award recipient, Jenna O'Neill, MD, was announced at the Skin of Color Society Reception at Loews Miami Beach Hotel in Miami Beach, FL. Among the 60 attendees, AMBI and Valeant Pharmaceuticals representatives were on hand to honor Ms. O'Neill for her contribution to dermatological research in skin of color, specifically in characterizing the genetic basis of central centrifugal cicatricial alopecia. For more information on AMBI and Valeant Pharmaceuticals, please visit: www.shopambi.com and www.valeant.com.

About AMBI® Skincare 
AMBI® Skincare is one of the brands under Valeant Pharmaceuticals North America. AMBI, a trusted name in cleansers and moisturizers for skin of color, has a legacy of skin care designed to provide smooth, even-toned, flawless-looking skin. Introduced in 1966, the brand has been used and trusted by women with richer skin tones for decades to provide quality products that meet skin of color needs.  The AMBI® Brand is best known for its fade creams, which help fade dark spots and skin discolorations to restore flawless, natural skin tone. The brand is part of the Valeant portfolio that also includes Kinerase, AcneFree, CeraVe and more.

About Valeant Pharmaceuticals International, Inc. 
Valeant Consumer Products, a division of Valeant Pharmaceuticals North America LLC, (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

 

 


'/>"/>
SOURCE AMBI Skincare
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Shire Supports Rare Disease Day 2013
2. KemPharm Supports Recent FDA Recommendations for Hydrocodone-Containing Compounds and Abuse-Deterrent Opioids
3. National Patient Advocate Foundation Supports 340B Drug Discount Program Review Identifying Risks to Underinsured Patients
4. Varian Medical Systems Supports Program to Tap Brain Power of Research and Development Community in Russia
5. Ameritox Leadership Supports Lawmakers, Pain Practitioners and Patients Confronting Crisis in Pain Medication Abuse
6. US Patent Granted to RBC Life Sciences for Supplement that Supports Cognitive Function
7. Amgen Backs States Efforts To Enact Biosimilar Legislation That Allows For Substitution And Supports Patient Safety
8. Novo Nordisk Supports Four San Francisco-based Organizations In Fight Against Diabetes
9. JAMA Study Demonstrates Efficacy of Life Technologies Lung Cancer Test in Detecting Early Metastases, Supports Screening for Lung Cancer
10. H. D. Smith Supports Local Hospitals, Nursing Homes, Clinics And Independent Retail Pharmacies Throughout Hurricane Sandy
11. Reproductive Medicine Associates of New York supports the ASRM endorsement of Oocyte Cryopreservation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... Neurology and Orphan Diseases, today announced that President & CEO ... conferences: SeeThru Equity MicroCap Conference   ... City , NY When: Tuesday, May 31 st ... Where: Grand Hyatt Hotel, 109 East 42 nd ...
(Date:5/26/2016)... -- According to a new market report published ... Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - ... valued at US$ 5.89 Bn in 2014 and is anticipated ... 2023 to reach US$ 7.99 Bn in 2023. ... free drug delivery devices and the market is estimated based ...
(Date:5/26/2016)... TARE (Transarterial Radio-embolization) Using ... and Overall Decreased Use of Hospital Resource ... specialist healthcare company, has today announced the publication ... of ISPOR (International Society for Pharmacoeconomics and Outcomes ... using yttrium-90 glass microspheres is associated with cost ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of ... Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who ... this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program ...
(Date:5/27/2016)... ... 27, 2016 , ... With over 60 percent of acute stroke survivors being ... product to aid in the rehabilitation process has steadily increased. Ekso Bionics had been ... hemiplegia due to stroke. , Ekso Bionics has now received clearance from the U.S. ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... help educate the many who are unaware of the plight of aphasia. In ... run within the “Stroke Awareness” campaign. , The link between stroke and aphasia ...
(Date:5/27/2016)... ... , ... Aimed at nurses and employees in the health care world, this ... the nursing and health care industry. It also provides insight to the developing trends ... , As the nursing industry is coming out of one of the biggest recessions ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... Despite last ... meeting, expect Janet Yellen and company to wait until March 2017 for an interest ... University’s J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) ...
Breaking Medicine News(10 mins):